Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial

Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 5

Abstract

The online version of this article (doi:10.1208/s12248-014-9631-6) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Kelong Han, Jin Jin, Mauricio Maia, John Lowe, Martina A. Sersch, David E. Allison

Keywords

Related Articles

Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus

Viruses deliver their genome into host cells where they subsequently replicate and multiply. A variety of relevant strategies have evolved by which viruses gain intracellular access and utilize cellular machinery for the...

Development and characterization of a recombinant madin-darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1)

Multidrug resistance-associated protein 1 (MRP1) is one of the major proteins shown to mediate efflux transport of a broad range of antitumor drugs, glucuronide conjugates, and glutathione, in addition to endogenous subs...

Multiple Imputation of Missing Covariates in NONMEM and Evaluation of the Method’s Sensitivity to η-Shrinkage

Multiple imputation (MI) is an approach widely used in statistical analysis of incomplete data. However, its application to missing data problems in nonlinear mixed-effects modelling is limited. The objective was to impl...

Neuropeptidomic Components Generated by Proteomic Functions in Secretory Vesicles for Cell–Cell Communication

Diverse neuropeptides participate in cell–cell communication to coordinate neuronal and endocrine regulation of physiological processes in health and disease. Neuropeptides are short peptides ranging in length fr...

Absorption Enhancers: Applications and Advances

Absorption enhancers are functional excipients included in formulations to improve the absorption of a pharmacologically active drug. The term absorption enhancer usually refers to an agent whose function is to increase...

Download PDF file
  • EP ID EP681086
  • DOI  10.1208/s12248-014-9631-6
  • Views 51
  • Downloads 0

How To Cite

Kelong Han, Jin Jin, Mauricio Maia, John Lowe, Martina A. Sersch, David E. Allison (2014). Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial. The AAPS Journal, 16(5), -. https://europub.co.uk/articles/-A-681086